Docket Management
Docket: 02N-0466 - Randomized Dose Response Study of Dryvax in Children Ages 2 to 5
Comment Number: EC -2

Accepted - Volume 3

Comment Record
Commentor Mrs. Janis Sherwood Date/Time 2002-10-31 09:57:26
Organization Terre Pharmaceuticals
Category Individual

Comments for FDA General
Questions
1. General Comments The proposed idea to test children ages 2-5 is a very bad idea. I do not think it should be done.




EC -2